AIDS-related Kaposi sarcoma: The role of local therapy for a systemic disease

Archives of Dermatology

Volumn 136, Issue 12, 2000, Pages 1554-1556

  Dezube, B J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTIRETROVIRUS AGENT; DAUNORUBICIN; DOXORUBICIN; LIPOSOME; PACLITAXEL; RETINOIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE CONTROL; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS LOAD;

ADMINISTRATION, CUTANEOUS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT OUTCOME; TRETINOIN;

EID: 0034532747     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. The epidemiology of AIDS-related neoplasms
2. Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk
3. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
4. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
5. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: A missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma
6. Retinoids as anticancer agents
7. Topical treatment of cutaneous lesions of Acquired Immunodeficiency Syndrome-related Kaposi sarcoma using Alitretinoin gel: Results of phase 1 and 2 trials
8. AIDS-related Kaposi's sarcoma: Clinical features, staging, and treatment
9. Psychosocial considerations in the therapy of epidemic Kaposi's sarcoma
10. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
11. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
12. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic) gel
13. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with infection
14. The role of radiation therapy in the management of HIV-related Kaposi's sarcoma
15. Palliative treatment of epidemic Kaposi sarcoma of the feet
16. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma
17. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
18. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
19. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
20. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV Clinical Trials Network study
21. Oral 9-cis-retinoic acid is active in AIDS related Kaposi's sarcoma: AIDS Malignancy Consortium Study 002
22. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group study
23. Activity of thalidomide in AIDS-related Kaposi's sarcoma
24. Angiogenesis inhibitor col-3 in the treatment of HIV-related Kaposi's sarcoma: A phase I AIDS Malignancy Consortium Study
25. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma